Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Nonlymphoblastic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00530699
What this trial is testing

Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
AstraZeneca 30
Early research (Phase 1)Study completedNCT01842139
What this trial is testing

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more
University of Chicago 7
Testing effectiveness (Phase 2)Looking for participantsNCT05580601
What this trial is testing

Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Children's Hospital Medical Center, Cincinnati 20
Large-scale testing (Phase 3)Study completedNCT00260832
What this trial is testing

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Eisai Inc. 485
Early research (Phase 1)Study completedNCT04714372
What this trial is testing

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyeloid LeukemiaMonocytic Leukemia
Masonic Cancer Center, University of Minnesota 9
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT03450512
What this trial is testing

Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire, Amiens 170
Testing effectiveness (Phase 2)Ended earlyNCT02418000
What this trial is testing

E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

Who this might be right for
AMLMDSCMML
Spirita Oncology, LLC 27
Not applicableLooking for participantsNCT06782971
What this trial is testing

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

Who this might be right for
AML - Acute Myeloid Leukemia
Clinical Hub for Interventional Research (CHOIR) 25
Early research (Phase 1)Study completedNCT03358719
What this trial is testing

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaBlasts 30 Percent or Less of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia+3 more
Roswell Park Cancer Institute 8
Not applicableUnknownNCT01106144
What this trial is testing

Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia

Who this might be right for
Patients With Acute Myeloid LeukemiaPatients Receiving Induction/Consolidation Chemotherapy
Samsung Medical Center 500
Not applicableStudy completedNCT00899652
What this trial is testing

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 149
Not applicableStudy completedNCT02921815
What this trial is testing

Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
Celgene 84
Early research (Phase 1)Looking for participantsNCT06366789
What this trial is testing

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML With Gene Mutations
Lomond Therapeutics Holdings, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01912274
What this trial is testing

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Helsinn Healthcare SA 50
Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)Ended earlyNCT05358808
What this trial is testing

ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
TC Biopharm 16
Early research (Phase 1)Active Not RecruitingNCT05001828
What this trial is testing

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
Polaris Group 38
Not applicableStudy completedNCT01321385
What this trial is testing

Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 97
Next Page